Summit Therapeutics (SMMT) Return on Assets (2020 - 2025)
Summit Therapeutics' (SMMT) quarterly Return on Assets came in at 0.0% in Q3 2025, little changed YoY from 0.0% in Q3 2024, and up 34.12% on a QoQ basis from 0.0% in Q2 2025.
Summit Therapeutics (SMMT) Return on Assets (2020 - 2025) Analysis & Trends
Summit Therapeutics (SMMT) has 6 years of Return on Assets data on file, last reported at 0.0% in Q3 2025.
- Quarterly Return on Assets changed 0.0% year-over-year to 0.0% in Q3 2025, while the trailing twelve-month figure through Sep 2025 was 0.0% (changed 0.0% YoY) and the FY2024 annual result came in at 0.06%, down 5.0% from the prior year.
- Return on Assets rose to 0.0% in Q3 2025, from 0.0% in the prior quarter.
- In the past five years, Return on Assets ranged from a high of 0.0% in Q4 2022 to a low of 0.03% in Q4 2023.
- A 5-year average of 0.01% and a median of 0.01% in 2022 frame the typical range for Return on Assets.
- Annual changes were most pronounced in 2023 — Return on Assets fell 3 bps — and 2024, when it gained 2 bps.
- Tracing SMMT's Return on Assets over 5 years: stood at 0.01% in 2021, then surged by 74 bps to 0.0% in 2022, then tumbled by 1489 bps to 0.03% in 2023, then surged by 83 bps to 0.01% in 2024, then surged by 52 bps to 0.0% in 2025.
- The last three Return on Assets figures came in at 0.0% (Q3 2025), 0.0% (Q2 2025), and 0.0% (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -0.01% |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.00% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 0.00% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.00% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 0.00% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 0.00% |
| 10 | Summit Therapeutics | 10.59 Bn | 9.90 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 0.00% |
| Jun 30, 2025 | 0.00% |
| Mar 31, 2025 | 0.00% |
| Dec 31, 2024 | -0.01% |
| Sep 30, 2024 | 0.00% |
| Jun 30, 2024 | -0.01% |
| Mar 31, 2024 | -0.01% |
| Dec 31, 2023 | -0.03% |
| Sep 30, 2023 | -0.03% |
| Jun 30, 2023 | -0.02% |
| Mar 31, 2023 | -0.01% |
| Dec 31, 2022 | 0.00% |
| Sep 30, 2022 | -0.01% |
| Jun 30, 2022 | -0.01% |
| Mar 31, 2022 | -0.01% |
| Dec 31, 2021 | -0.01% |
| Sep 30, 2021 | -0.01% |
| Jun 30, 2021 | -0.01% |
| Mar 31, 2021 | -0.01% |
| Dec 31, 2020 | -0.01% |